Integrated Filing — IndAS
General information about company
| Scrip Code |
532321 |
| NSE Symbol |
ZYDUSLIFE |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE010B01027 |
| Name of company |
ZYDUS LIFESCIENCES LIMITED |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2025 |
| Date of end of financial year |
31-03-2026 |
| Date of board meeting when results were approved |
19-05-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
08-05-2026 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Fourth quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Audited |
| Segment Reporting |
Multi segment |
| Description of single segment |
|
| Start date and time of board meeting |
19-05-2026 12:00:00 |
| End date and time of board meeting |
19-05-2026 14:00:00 |
| Whether cash flow statement is applicable on company |
Yes |
| Type of cash flow statement |
Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
7,58,700.00 |
27,14,840.00 |
|
Other income |
13,420.00 |
50,950.00 |
|
Total income |
7,72,120.00 |
27,65,790.00 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
1,34,720.00 |
5,10,960.00 |
| (b) |
Purchases of stock-in-trade |
97,170.00 |
3,07,050.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
(34,260.00) |
(88,750.00) |
| (d) |
Employee benefit expense |
1,23,880.00 |
4,41,790.00 |
| (e) |
Finance costs |
12,300.00 |
43,890.00 |
| (f) |
Depreciation, depletion and amortisation expense
|
50,840.00 |
1,40,800.00 |
| (f) |
Other Expenses |
| 1 |
Other expenses |
2,46,240.00 |
8,24,330.00 |
| 2 |
Net (gain)/ loss on foreign currency transactions |
(64,490.00) |
(1,28,050.00) |
|
Total other expenses |
1,81,750.00 |
6,96,280.00 |
|
Total expenses |
5,66,400.00 |
20,52,020.00 |
| 3 |
Total profit before exceptional items and tax |
2,05,720.00 |
7,13,770.00 |
| 4 |
Exceptional items |
(39,750.00) |
(51,660.00) |
| 5 |
Total profit before tax |
1,65,970.00 |
6,62,110.00 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
52,560.00 |
1,37,950.00 |
| 8 |
Deferred tax |
(20,720.00) |
21,520.00 |
| 9 |
Total tax expenses |
31,840.00 |
1,59,470.00 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
1,34,130.00 |
5,02,640.00 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
(30.00) |
9,710.00 |
| 16 |
Total profit (loss) for period |
1,34,100.00 |
5,12,350.00 |
| 17 |
Other comprehensive income net of taxes |
(48,340.00) |
(77,480.00) |
| 18 |
Total Comprehensive Income for the period |
85,760.00 |
4,34,870.00 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
1,27,250.00 |
5,04,000.00 |
|
Total profit or loss, attributable to non-controlling interests |
6,850.00 |
8,350.00 |
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
79,020.00 |
4,26,730.00 |
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
6,740.00 |
8,140.00 |
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
10,060.00 |
10,060.00 |
|
Face value of equity share capital |
1 |
1 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
27,01,080.00 |
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
12.65 |
50.09 |
|
Diluted earnings (loss) per share from continuing operations |
12.65 |
50.09 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
12.65 |
50.09 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
12.65 |
50.09 |
| 24 |
Debt equity ratio |
|
|
| 25 |
Debt service coverage ratio |
|
|
| 26 |
Interest service coverage ratio |
|
|
| 27 |
Disclosure of notes on financial results |
|
Remarks
Statement of Asset and Liabilities
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-04-2025 |
| Date of end of reporting period |
31-03-2026 |
| Whether results are audited or unaudited |
Audited |
| Nature of report standalone or consolidated |
Consolidated |
|
Assets |
| 1 |
Non-current assets |
|
Property, plant and equipment |
9,23,070.00 |
|
Capital work-in-progress |
1,16,570.00 |
|
Investment property |
0.00 |
|
Goodwill |
7,54,270.00 |
|
Other intangible assets |
7,33,240.00 |
|
Intangible assets under development |
2,53,280.00 |
|
Biological assets other than bearer plants |
0.00 |
|
Investments accounted for using equity method |
1,16,660.00 |
|
Non-current financial assets |
|
|
Non-current investments |
59,750.00 |
|
Trade receivables, non-current |
0.00 |
|
Loans, non-current |
20.00 |
|
Other non-current financial assets |
|
| 1 |
Other Financial Assets |
3,440.00 |
|
Total of other non-current financial assets |
3,440.00 |
|
Total non-current financial assets |
63,210.00 |
|
Deferred tax assets (net) |
2,10,860.00 |
|
Other non-current assets |
|
| 1 |
Other non-current assets |
68,420.00 |
| 2 |
Assets for Current tax (Net) |
10,470.00 |
|
Total of other non-current assets |
78,890.00 |
|
Total non-current assets |
32,50,050.00 |
| 2 |
Current assets |
|
|
Inventories |
5,62,810.00 |
|
Current financial asset |
|
|
Current investments |
5,77,580.00 |
|
Trade receivables, current |
5,41,570.00 |
|
Cash and cash equivalents |
85,520.00 |
|
Bank balance other than cash and cash equivalents |
56,140.00 |
|
Loans, current |
370.00 |
|
Other current financial assets |
|
|
Total of other current financial assets |
21,690.00 |
|
Total current financial assets |
12,82,870.00 |
|
Current tax assets (net) |
|
|
Other current assets |
|
| 1 |
Other current assets |
1,44,930.00 |
|
Total of other current assets |
1,44,930.00 |
|
Total current assets |
19,90,610.00 |
| 3 |
Non-current assets classified as held for sale |
0.00 |
| 4 |
Regulatory deferral account debit balances and related deferred tax Assets |
0.00 |
|
Total assets |
52,40,660.00 |
|
Equity and liabilities |
|
| 1 |
Equity |
|
|
Equity attributable to owners of parent |
|
|
Equity share capital |
10,060.00 |
|
Other equity |
27,01,080.00 |
|
Total equity attributable to owners of parent |
27,11,140.00 |
|
Non controlling interest |
2,47,080.00 |
|
Total equity |
29,58,220.00 |
| 2 |
Liabilities |
|
|
Non-current liabilities |
|
|
Non-current financial liabilities |
|
|
Borrowings, non-current |
3,18,800.00 |
|
Trade payables, non-current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
0.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
0.00 |
|
Total Trade payable |
0.00 |
|
Other non-current financial liabilities |
|
| 1 |
Lease liabilities |
66,830.00 |
| 2 |
Other financial liabilities |
1,07,640.00 |
|
Total of other non-current financial liabilities |
1,74,470.00 |
|
Total non-current financial liabilities |
4,93,270.00 |
|
Provisions, non-current |
44,530.00 |
|
Deferred tax liabilities (net) |
1,73,400.00 |
|
Deferred government grants, Non-current |
0.00 |
|
Other non-current liabilities |
|
| 1 |
Other Non-Current Liabilities |
50.00 |
|
Total of other non-current liabilities |
50.00 |
|
Total non-current liabilities |
7,11,250.00 |
|
Current liabilities |
|
|
Current financial liabilities |
|
|
Borrowings, current |
8,58,150.00 |
|
Trade payables, current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
15,400.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
2,69,110.00 |
|
Total Trade payable |
2,84,510.00 |
|
Other current financial liabilities |
|
| 1 |
Lease liabilities |
5,820.00 |
| 2 |
Other financial liabilities |
2,90,460.00 |
|
Total of other current financial liabilities |
2,96,280.00 |
|
Total current financial liabilities |
14,38,940.00 |
|
Other current liabilities |
47,770.00 |
| 1 |
Other current liabilities |
47,770.00 |
|
Total of other current liabilities |
47,770.00 |
|
Provisions, current |
47,850.00 |
|
Current tax liabilities (Net) |
36,630.00 |
|
Deferred government grants, Current |
0.00 |
|
Total current liabilities |
15,71,190.00 |
| 3 |
Liabilities directly associated with assets in disposal group classified as held for sale |
|
| 4 |
Regulatory deferral account credit balances and related deferred tax liability |
|
|
Total liabilities |
22,82,440.00 |
|
Total equity and liabilites |
52,40,660.00 |
|
Disclosure of notes on assets and liabilities |
|
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| Date of end of reporting
period |
31-03-2026 |
31-03-2026 |
| Whether results are audited
or unaudited |
Unaudited |
Audited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
| 1 |
Pharmaceuticals |
5,77,610.00 |
22,41,210.00 |
| 2 |
Consumer products |
1,48,340.00 |
3,95,400.00 |
| 3 |
Medical technologies |
32,750.00 |
78,230.00 |
|
Total Segment Revenue |
7,58,700.00 |
27,14,840.00 |
|
Less: Inter segment revenue |
|
|
|
Revenue from operations |
7,58,700.00 |
27,14,840.00 |
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
| 1 |
Pharmaceuticals |
1,93,960.00 |
7,04,880.00 |
| 2 |
Consumer products |
17,640.00 |
26,710.00 |
| 3 |
Medical technologies |
(5,880.00) |
(17,820.00) |
|
Total Profit before tax |
2,05,720.00 |
7,13,770.00 |
|
i. Finance cost |
|
|
|
ii. Other Unallocable Expenditure net off Unallocable income |
|
|
|
Profit before tax |
2,05,720.00 |
7,13,770.00 |
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
| 1 |
Pharmaceuticals |
35,79,830.00 |
35,79,830.00 |
| 2 |
Consumer products |
10,30,620.00 |
10,30,620.00 |
| 3 |
Medical technologies |
6,30,210.00 |
6,30,210.00 |
|
Total Segment Asset |
52,40,660.00 |
52,40,660.00 |
|
Un-allocable Assets |
0.00 |
0.00 |
|
Net Segment Asset |
52,40,660.00 |
52,40,660.00 |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
| 1 |
Pharmaceuticals |
11,96,840.00 |
11,96,840.00 |
| 2 |
Consumer products |
4,47,900.00 |
4,47,900.00 |
| 3 |
Medical technologies |
6,37,700.00 |
6,37,700.00 |
|
Total Segment Liabilities |
22,82,440.00 |
22,82,440.00 |
|
Un-allocable Liabilities |
0.00 |
0.00 |
|
Net Segment Liabilities |
22,82,440.00 |
22,82,440.00 |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
Items that will not be reclassified to profit or loss |
(6,940.00) |
(3,290.00) |
|
Total Amount of items that will not be reclassified to profit and loss |
(6,940.00) |
(3,290.00) |
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
1,650.00 |
1,350.00 |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
| 1 |
Items that will be reclassified to profit or loss |
(39,890.00) |
(72,980.00) |
| 2 |
Share of OCI of joint ventures (net of tax) |
140.00 |
140.00 |
|
Total Amount of items that will be reclassified to profit and loss |
(39,750.00) |
(72,840.00) |
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
0.00 |
0.00 |
| 5 |
Total Other comprehensive income |
(48,340.00) |
(77,480.00) |
Cash flow statement, indirect
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
|
Statement of cash flows |
|
|
Cash flows from used in operating
activities |
|
|
Profit before tax |
6,62,110.00 |
|
Adjustments for reconcile profit (loss) |
|
|
Adjustments for finance costs |
36,500.00 |
|
Adjustments for decrease (increase) in inventories |
(41,240.00) |
|
Adjustments for decrease (increase) in trade receivables, current |
(85,810.00) |
|
Adjustments for decrease (increase) in trade receivables, non-current
|
0.00 |
|
Adjustments for decrease (increase) in other current assets |
(46,180.00) |
|
Adjustments for decrease (increase) in other non-current assets |
0.00 |
|
Adjustments for other financial assets, non-current |
0.00 |
|
Adjustments for other financial assets, current |
0.00 |
|
Adjustments for other bank balances |
0.00 |
|
Adjustments for increase (decrease) in trade payables, current |
(79,510.00) |
|
Adjustments for increase (decrease) in trade payables, non-current |
0.00 |
|
Adjustments for increase (decrease) in other current liabilities |
(9,630.00) |
|
Adjustments for increase (decrease) in other non-current liabilities
|
0.00 |
|
Adjustments for depreciation and amortisation expense |
1,40,800.00 |
|
Adjustments for impairment loss reversal of impairment loss recognised
in profit or loss |
0.00 |
|
Adjustments for provisions, current |
5,490.00 |
|
Adjustments for provisions, non-current |
(5,400.00) |
|
Adjustments for other financial liabilities, current |
0.00 |
|
Adjustments for other financial liabilities, non-current |
0.00 |
|
Adjustments for unrealised foreign exchange losses gains |
(1,75,330.00) |
|
Adjustments for dividend income |
120.00 |
|
Adjustments for interest income |
42,250.00 |
|
Adjustments for share-based payments |
0.00 |
|
Adjustments for fair value losses (gains) |
(2,920.00) |
|
Adjustments for undistributed profits of associates |
0.00 |
|
Other adjustments for which cash effects are investing or financing
cash flow |
(230.00) |
|
Other adjustments to reconcile profit (loss) |
0.00 |
|
Other adjustments for non-cash items |
14,480.00 |
|
Share of profit and loss from partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Total adjustments for reconcile
profit (loss) |
(2,91,350.00) |
|
Net cash flows from (used in)
operations |
3,70,760.00 |
|
Dividends received |
0.00 |
|
Interest paid |
0.00 |
|
Interest received |
0.00 |
|
Income taxes paid (refund) |
1,59,100.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
operating activities |
2,11,660.00 |
|
Cash flows from used in
investing activities |
|
|
Cash flows from losing control of subsidiaries or other businesses |
0.00 |
|
Cash flows used in obtaining control of subsidiaries or other businesses |
5,87,930.00 |
|
Other cash receipts from sales of equity or debt instruments of other
entities |
11,200.00 |
|
Other cash payments to acquire equity or debt instruments of other entities
|
34,520.00 |
|
Other cash receipts from sales of interests in joint ventures |
0.00 |
|
Other cash payments to acquire interests in joint ventures |
0.00 |
|
Cash receipts from share of profits of partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Cash payment for investment in partnership firm or association of persons or
limited liability partnerships |
0.00 |
|
Proceeds from sales of property, plant and equipment |
2,490.00 |
|
Purchase of property, plant and equipment |
3,39,400.00 |
|
Proceeds from sales of investment property |
0.00 |
|
Purchase of investment property |
0.00 |
|
Proceeds from sales of intangible assets |
0.00 |
|
Purchase of intangible assets |
0.00 |
|
Proceeds from sales of intangible assets under development |
0.00 |
|
Purchase of intangible assets under development |
0.00 |
|
Proceeds from sales of goodwill |
0.00 |
|
Purchase of goodwill |
0.00 |
|
Proceeds from biological assets other than bearer plants |
0.00 |
|
Purchase of biological assets other than bearer plants |
0.00 |
|
Proceeds from government grants |
0.00 |
|
Proceeds from sales of other long-term assets |
0.00 |
|
Purchase of other long-term assets |
0.00 |
|
Cash advances and loans made to other parties |
0.00 |
|
Cash receipts from repayment of advances and loans made to other parties |
7,320.00 |
|
Cash payments for future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Cash receipts from future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Dividends received |
120.00 |
|
Interest received |
42,720.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
68,390.00 |
|
Net cash flows from (used in)
investing activities |
(8,29,610.00) |
|
Cash flows from used in
financing activities |
|
|
Proceeds from changes in ownership interests in subsidiaries |
0.00 |
|
Payments from changes in ownership interests in subsidiaries |
0.00 |
|
Proceeds from issuing shares |
0.00 |
|
Proceeds from issuing other equity instruments |
0.00 |
|
Payments to acquire or redeem entity's shares |
0.00 |
|
Payments of other equity instruments |
0.00 |
|
Proceeds from exercise of stock options |
0.00 |
|
Proceeds from issuing debentures notes bonds etc |
0.00 |
|
Proceeds from borrowings |
8,26,020.00 |
|
Repayments of borrowings |
96,790.00 |
|
Payments of lease liabilities |
2,550.00 |
|
Dividends paid |
1,10,630.00 |
|
Interest paid |
35,360.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
19,020.00 |
|
Net cash flows from (used in)
financing activities |
5,99,710.00 |
|
Net increase (decrease) in cash
and cash equivalents before effect of exchange rate changes |
(18,240.00) |
|
Effect of exchange rate changes
on cash and cash equivalents |
|
|
Effect of exchange rate changes on cash and cash equivalents |
21,080.00 |
|
Net increase (decrease) in cash
and cash equivalents |
2,840.00 |
|
Cash and cash equivalents cash flow statement at beginning of period
|
82,680.00 |
|
Cash and cash equivalents cash
flow statement at end of period |
85,520.00 |
Details of Impact of Audit Qualification
Amount in (Lakhs)
| Whether results are audited or unaudited |
Audited |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
| Auditor's opinion |
|
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015:
The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified
opinion for the period on Standalone results |
Yes |
| Sr No. |
Audit firm's name |
Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI |
Certificate valid upto |
| 1 |
Deloitte Haskins & Sells LLP |
Yes |
31-07-2027 |